FDA Inspection 1009224 — The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C.

The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C. — FEI 3003969128

The FDA completed an inspection of The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C. on Mar 3, 2017 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 3, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1227821 CFR 1271.75(a)(2)Risks associated with xenotransplantation